CS274502B2 - Method of glutaramide's derivatives' s-enantiomers production - Google Patents

Method of glutaramide's derivatives' s-enantiomers production Download PDF

Info

Publication number
CS274502B2
CS274502B2 CS296589A CS296589A CS274502B2 CS 274502 B2 CS274502 B2 CS 274502B2 CS 296589 A CS296589 A CS 296589A CS 296589 A CS296589 A CS 296589A CS 274502 B2 CS274502 B2 CS 274502B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
hydrogen
cleaved
indanyl
give
Prior art date
Application number
CS296589A
Other languages
Czech (cs)
English (en)
Other versions
CS296589A2 (en
Inventor
John Ch Dr Danillewicz
Michael T Dr Williams
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS296589A2 publication Critical patent/CS296589A2/cs
Publication of CS274502B2 publication Critical patent/CS274502B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
CS296589A 1988-05-19 1989-05-17 Method of glutaramide's derivatives' s-enantiomers production CS274502B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents

Publications (2)

Publication Number Publication Date
CS296589A2 CS296589A2 (en) 1990-09-12
CS274502B2 true CS274502B2 (en) 1991-04-11

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
CS296589A CS274502B2 (en) 1988-05-19 1989-05-17 Method of glutaramide's derivatives' s-enantiomers production

Country Status (29)

Country Link
EP (1) EP0342850B1 (de)
JP (1) JPH072699B2 (de)
KR (1) KR920000561B1 (de)
CN (1) CN1015361B (de)
AT (1) ATE76399T1 (de)
AU (1) AU602813B2 (de)
CA (1) CA1331197C (de)
CS (1) CS274502B2 (de)
DD (1) DD283772A5 (de)
DE (1) DE68901582D1 (de)
DK (1) DK172032B1 (de)
EG (1) EG19007A (de)
ES (1) ES2037418T3 (de)
FI (1) FI93541C (de)
GB (1) GB8811873D0 (de)
GR (1) GR3004968T3 (de)
HU (1) HU205067B (de)
IE (1) IE60724B1 (de)
IL (1) IL90267A (de)
MX (1) MX16067A (de)
MY (1) MY104735A (de)
NO (1) NO173647C (de)
NZ (1) NZ229186A (de)
PH (1) PH26740A (de)
PL (1) PL154813B1 (de)
PT (1) PT90584B (de)
SU (1) SU1766251A3 (de)
YU (1) YU47973B (de)
ZA (1) ZA893696B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
DE69300826T2 (de) * 1993-09-22 1996-04-18 Pfizer Res & Dev Hydrierung.
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en) * 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
CN108685889A (zh) 2012-08-24 2018-10-23 诺华股份有限公司 用于治疗特征为心房增大或重构的疾病的nep抑制剂
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
US20180311241A1 (en) 2015-10-29 2018-11-01 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제

Also Published As

Publication number Publication date
PL279491A1 (en) 1989-11-27
FI93541B (fi) 1995-01-13
DK240889A (da) 1989-11-20
SU1766251A3 (ru) 1992-09-30
IE891613L (en) 1989-11-19
FI892386A0 (fi) 1989-05-18
AU602813B2 (en) 1990-10-25
AU3490489A (en) 1989-11-23
FI93541C (fi) 1995-04-25
CN1037704A (zh) 1989-12-06
MX16067A (es) 1993-10-01
FI892386A (fi) 1989-11-20
IE60724B1 (en) 1994-08-10
NO173647C (no) 1994-01-12
ES2037418T3 (es) 1993-06-16
NO892002D0 (no) 1989-05-18
DD283772A5 (de) 1990-10-24
JPH072699B2 (ja) 1995-01-18
PH26740A (en) 1992-09-28
ZA893696B (en) 1990-12-28
KR920000561B1 (ko) 1992-01-16
PL154813B1 (en) 1991-09-30
EP0342850B1 (de) 1992-05-20
HU205067B (en) 1992-03-30
EG19007A (en) 1994-11-30
JPH0222256A (ja) 1990-01-25
CA1331197C (en) 1994-08-02
CS296589A2 (en) 1990-09-12
NO173647B (no) 1993-10-04
YU102289A (en) 1991-06-30
GB8811873D0 (en) 1988-06-22
PT90584B (pt) 1994-09-30
PT90584A (pt) 1989-11-30
ATE76399T1 (de) 1992-06-15
IL90267A0 (en) 1989-12-15
KR900017993A (ko) 1990-12-20
EP0342850A1 (de) 1989-11-23
DK172032B1 (da) 1997-09-22
HUT53596A (en) 1990-11-28
NO892002L (no) 1989-11-20
DE68901582D1 (de) 1992-06-25
DK240889D0 (da) 1989-05-18
NZ229186A (en) 1990-10-26
YU47973B (sh) 1996-08-13
GR3004968T3 (de) 1993-04-28
CN1015361B (zh) 1992-02-05
IL90267A (en) 1993-08-18
MY104735A (en) 1994-05-31

Similar Documents

Publication Publication Date Title
JP2883297B2 (ja) 合成興奮性アミノ酸
US4153803A (en) Cholesterol-lowering phenoxyalkanoic acid esters
US4562263A (en) Process for producing 3-(3,4-dihydroxyphenyl) serine
CS274502B2 (en) Method of glutaramide's derivatives' s-enantiomers production
HU221194B1 (en) Ltb4 antagonist benzopyran derivatives, process for producing them, and pharmaceuticals containing them, and the use of them as ltb4 antagonist for medicaments
WO1997014670A1 (en) Lignans, a process for their production and pharmaceutical compositions and uses thereof
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
SU910118A3 (ru) Способ получени N @ -глюкофуранозид-6-ил-N @ -нитрозомочевины
JPH02306947A (ja) キラルβ―アミノ酸の製造方法
AU610379B2 (en) New heteroarotinoid derivatives, processes for preparing them and pharmaceutical compositions containing them
US5252738A (en) Process for the preparation of racemic and optically active 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and its precursors
GB2036744A (en) Eburnane derivatives
CH619468A5 (de)
EP1793828A2 (de) Fibratverbindung mit prar-agonistenaktivität
DK167018B1 (da) 3-furylamino-1-benzazepiner samt fremgangsmaade til fremstillig deraf
EP0385423B1 (de) Verfahren zur Herstellung der optischen Isomeren von 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure-ethyl-ester und 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure- 2-(N-methyl-N-phenylmethylamino)ethyl ester
HU182338B (en) Process for producing bis-hydroxybenzyl derivatives and pharmaceutical compositions containing them
DK169100B1 (da) (L)-Menthyl-2-oxo-4-phenylbutyrat samt fremgangsmåde til fremstilling og isolering af i det væsentlige ren (R)-2-hydroxy-4-phenylsmørsyre og estere deraf
SK568590A3 (en) Glutaric acid derivatives and method for the preparation thereof, and intermediate product of said method
US2957877A (en) New process for the preparation of organic alkaloid-like compounds
KR850000569B1 (ko) 카르니틴의 아실-유도체 제조방법
Brouillette et al. Preparation of the Racemate and Enantiomers of 3-Hydroxy-5, 5-dimethylhexanoic Acid
CS208142B2 (cs) Způsob výroby nových substituovaných benzocykloalkenylkarboxylových kyselin a popřípadě jejich esterů nebo amidů
JPH02149561A (ja) 新規カテコール誘導体

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20050517